These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17662393)

  • 1. Means and ends of statins and low-density lipoprotein cholesterol lowering.
    LaRosa JC
    J Am Coll Cardiol; 2007 Jul; 50(5):419-20. PubMed ID: 17662393
    [No Abstract]   [Full Text] [Related]  

  • 2. Low-density lipoprotein reduction and cancer: not definitive but provocative.
    DeMaria AN; Ben-Yehuda O
    J Am Coll Cardiol; 2007 Jul; 50(5):421-2. PubMed ID: 17662394
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized statin trials.
    Alsheikh-Ali AA; Maddukuri PV; Han H; Karas RH
    J Am Coll Cardiol; 2007 Jul; 50(5):409-18. PubMed ID: 17662392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reductase inhibitor therapy of hypercholesterolemia.
    Kreisberg RA
    Trans Am Clin Climatol Assoc; 1991; 102():153-63; discussion 163-5. PubMed ID: 2130558
    [No Abstract]   [Full Text] [Related]  

  • 5. Cardiology patient page. Statin intolerance.
    Fitchett DH; Hegele RA; Verma S
    Circulation; 2015 Mar; 131(13):e389-91. PubMed ID: 25825402
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pharmacokinetics of statins].
    Fonseca FA
    Arq Bras Cardiol; 2005 Oct; 85 Suppl 5():9-14. PubMed ID: 16400390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship of statins to rhabdomyolysis, malignancy, and hepatic toxicity: evidence from clinical trials.
    Alsheikh-Ali AA; Karas RH
    Curr Atheroscler Rep; 2009 Mar; 11(2):100-4. PubMed ID: 19228482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescribing statins: the real issues.
    Hamilton-Craig IR
    Med J Aust; 2014 May; 200(8):440-1. PubMed ID: 24794593
    [No Abstract]   [Full Text] [Related]  

  • 9. JAMA patient page. Statins.
    Sugerman DT; Livingston EH; Lynm C
    JAMA; 2013 Apr; 309(13):1419. PubMed ID: 23549589
    [No Abstract]   [Full Text] [Related]  

  • 10. Statins and aortic stenosis in the context of ratio of low- to high-density lipoprotein cholesterol.
    Yilmaz MB
    J Am Coll Cardiol; 2007 Jul; 50(3):289-90; author reply 290. PubMed ID: 17631225
    [No Abstract]   [Full Text] [Related]  

  • 11. State of the art in cholesterol management: targeting multiple pathways.
    Turley SD
    Am J Manag Care; 2002 Feb; 8(2 Suppl):S29-32; discussion S45-7. PubMed ID: 11855699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ask the doctor. I've heard that taking statins can raise your risk of diabetes. Is this really true?
    Bhatt DL
    Harv Heart Lett; 2014 Jul; 24(11):2. PubMed ID: 25185274
    [No Abstract]   [Full Text] [Related]  

  • 13. Ask the doctor. Taking a cholesterol-lowering statin has brought down my bad cholesterol (LDL) to only 37 mg/dL. My liver and muscles are fine. The very low LDL worries my doctor. Should I change my regimen?
    Lee TH
    Harv Heart Lett; 2002 Oct; 13(2):8. PubMed ID: 12393347
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety of statins: effects on muscle and the liver.
    Vasudevan AR; Hamirani YS; Jones PH
    Cleve Clin J Med; 2005 Nov; 72(11):990-3, 996-1001. PubMed ID: 16315438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cholesterol-lowering with statins: are they all the same? - Summary of the Expert Symposium at the 53rd Annual Scientific Sessions of the American College of Cardiology.
    International Task Force for the Prevention of Coronary Heart Disease
    Timely Top Med Cardiovasc Dis; 2004 Sep; 8():E8. PubMed ID: 15543260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Ezetimib as combination partner in hypercholesteremia. Lowering LDL beyond the effect of statins].
    Sudhop T; von Bergmann K
    MMW Fortschr Med; 2003 Apr; 145(16):48-50. PubMed ID: 14606402
    [No Abstract]   [Full Text] [Related]  

  • 17. High-dose statin therapy: benefits and safety in aggressive lipid lowering.
    Toth PP; Davidson MH
    J Fam Pract; 2008 May; 57(5 Suppl High-Dose):S29-36. PubMed ID: 18662521
    [No Abstract]   [Full Text] [Related]  

  • 18. The influence of statin characteristics on their safety and tolerability.
    De Angelis G
    Int J Clin Pract; 2004 Oct; 58(10):945-55. PubMed ID: 15587774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence-based prediction of statin use with lipid-panel data from the National Health and Nutrition Examination Survey.
    Gorevski E; Bian B; Kelton CM; Martin Boone JE; Guo JJ
    Value Health; 2012 Jan; 15(1):32-8. PubMed ID: 22264969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins and low-density lipoprotein cholesterol levels.
    Cohen JS
    Am J Med; 2003 Jul; 115(1):74-5; author reply 75-6. PubMed ID: 12867244
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.